CMS Launches Medicare Advantage Directory: Key Implications

An Analytical Review of the New Regulatory Framework, Its Implications, and the Road Ahead

By Elena Pak, Credentialing Department, WCH

In February 2026, the Centers for Medicare & Medicaid Services announced plans to beta-launch a national federal directory of Medicare Advantage providers — hospitals, physicians, and other facilities — integrated directly into the agency’s Medicare Plan Finder tool. The move, grounded in a final rule that took effect November 17, 2025, and became applicable to Medicare Advantage organizations starting January 1, 2026, represents one of the most consequential transparency reforms in the program’s history.

For years, the Medicare Advantage provider directory system has been widely regarded as broken. Beneficiaries relying on plan-maintained directories to choose their coverage have routinely encountered outdated listings, unreachable providers, and facilities that no longer accept their plan — a phenomenon known in the industry as “ghost networks.” The consequences are not merely inconvenient. They are clinically serious, financially harmful, and, in a program serving more than 32 million Americans, structurally corrosive to the premise that Medicare Advantage represents a viable alternative to traditional Medicare.

The new CMS initiative marks a decisive shift in responsibility: from plan-level disclosure to federal oversight and centralized publication. Understanding what this reform does, why it matters, what it leaves unresolved, and how it fits within the broader debate over Medicare Advantage’s quality and accountability is essential for health system leaders, policymakers, payers, and advocates alike.

The Scale of the Ghost Network Problem

To appreciate the significance of CMS’s action, it is necessary to understand the severity of the problem it is designed to address. The evidence accumulated over the past decade paints a damning picture of systematic inaccuracy in Medicare Advantage provider directories.

A 2025 HHS Office of Inspector General data brief, drawing on analysis of 40 Medicare Advantage plans across 10 counties, found that on average 55% of behavioral health providers listed in plans’ networks did not provide any care to plan enrollees during the study period. In rural counties, the figure was even higher: an average of 63% of network providers were inactive, meaning they did not treat any of the plan’s members. Seven of the 40 analyzed plans had no in-network behavioral health providers in the studied counties at all — yet their directories suggested otherwise.

The OIG’s findings were consistent with a growing body of research and investigative reporting. A Senate Finance Committee study found that more than 80% of listed in-network mental health providers that staff attempted to contact were effectively “ghosts” — either unreachable, not accepting new patients, or not actually participating in the plan’s network. A 2025 consumer survey conducted by LexisNexis Risk Solutions found that one in three provider directory users had encountered outdated or incorrect information when searching for care. Meanwhile, a KFF analysis found that Medicare Advantage plans include, on average, only 48% of the physicians that accept traditional Medicare in their directories — raising questions not only about directory accuracy but about network adequacy itself.

The problem is structural, not incidental. Provider directories are maintained by individual plans, updated on irregular cycles, and subject to minimal real-time verification. Physicians and hospitals have little incentive to proactively notify plans of changes — their administrative burden is already substantial, and they may interact with dozens of different payer systems, each requiring different data formats and update processes. When a provider leaves a network, retires, or stops accepting new patients, the directory can lag behind reality for months or years.

The consequences ripple outward. Beneficiaries make enrollment decisions based on inaccurate information, believing their existing physicians are in-network when they are not. They later face unexpected out-of-network costs or are forced to find new providers mid-treatment. For those with complex or chronic conditions, mid-care disruptions carry real clinical risk. For behavioral health patients — a group particularly vulnerable to care discontinuity — the consequences of encountering a ghost network can be severe.

What the New CMS Rule Actually Requires

The regulatory framework underlying CMS’s federal directory initiative is established by final rule CMS-4208-F2, which the Trump administration finalized separately from the broader 2026 Medicare Advantage policy package in order to give plans maximum lead time to comply. The rule amends disclosure requirements under 42 CFR 422.111 and imposes several concrete obligations on Medicare Advantage organizations beginning with plan years starting January 1, 2026.

First and most fundamentally, Medicare Advantage organizations are now required to submit their provider directory data to CMS for publication on the Medicare Plan Finder. Previously, CMS operated MPF without requiring plans to supply standardized, machine-readable data for centralized display — plans maintained their own directories and CMS relied on other means to populate the comparison tool. Under the new rule, plans must supply current in-network provider and facility data directly to CMS.

Second, plans must update that data within 30 days of becoming aware of any changes — such as a provider leaving the network, changing practice locations, or closing to new patients. This 30-day update requirement represents a meaningful tightening of what had been a more permissive quarterly update standard.

Third, plans must attest annually to the accuracy of the data they provide. This attestation requirement introduces a formal accountability mechanism: plan executives must certify that the information CMS publishes on their behalf is correct.

It is worth noting, however, what the rule did not finalize. CMS declined to require plans to attest that their provider directory data is consistent with the data submitted to demonstrate network adequacy compliance under 42 CFR 422.116. The rationale offered was administrative: plans already attest separately that their networks meet adequacy requirements. Critics have argued, however, that separating these two attestations allows plans to maintain technical network adequacy on paper while fielding directories that do not accurately reflect the providers who are actually accessible to enrollees.

The timeline for implementation is also notable. CMS has indicated it will conduct a testing period before the provider directory data submitted under the new rule populates the 2027 Medicare Plan Finder. For 2026, the Plan Finder is using provider directory data sourced from third-party vendors as an interim measure. This means the full force of the new transparency regime will not be felt by beneficiaries until the 2027 Annual Election Period — a delay that, while operationally understandable, leaves a gap in accountability during 2026 open enrollment.

The Structural Context: Medicare Advantage Under Scrutiny

CMS’s directory reform does not exist in isolation. It is part of a broader pattern of tightening oversight of Medicare Advantage — a program that has grown explosively over the past decade but has attracted mounting scrutiny over its practices.

As of 2024, more than 32.8 million people, representing more than half of all Medicare beneficiaries, were enrolled in Medicare Advantage plans. The program’s rapid growth has made it one of the largest insurance markets in the country, with hundreds of billions of federal dollars flowing through private plan intermediaries each year. That scale has also brought intensifying regulatory and legislative attention.

In the years leading up to the 2026 directory rule, CMS and Congress took a series of steps to rein in practices that critics argued were compromising care quality and costing taxpayers through inflated risk-adjustment payments. Prior authorization abuses drew particular scrutiny, with CMS finalizing rules in 2024 that tightened the criteria plans may use to deny coverage and required faster decision timelines. A Senate Judiciary Committee investigation found that one major MA insurer had used what the committee characterized as “aggressive strategies” to maximize risk-adjustment payments. CMS also expanded audit activities to crack down on MA overpayments, a longstanding concern given the program’s reliance on risk-adjusted payments that have been subject to gaming.

The directory reform fits squarely within this trend. Inaccurate provider directories serve plan interests, at least in the short term, by creating the appearance of network breadth that may not exist in practice. By shifting the locus of directory publication from plans to CMS, and by requiring formal attestation of accuracy, the new rule raises the compliance stakes considerably. A plan that attests to accurate data that turns out to be materially wrong faces potential enforcement action — a risk calculus that differs sharply from the prior environment in which directory errors carried minimal consequences.

Implications for Hospitals and Health Systems

The CMS directory initiative has significant implications for hospitals and health systems, particularly those navigating increasingly fraught relationships with Medicare Advantage plans. In recent years, a notable number of major health systems have exited MA networks, citing inadequate reimbursement rates, prior authorization burdens, and administrative complexity. The centralized directory creates a new visibility layer that cuts in multiple directions for providers.

On one hand, the federal directory increases transparency around which hospitals are in-network for which plans — information that may prompt more informed enrollment decisions and reduce the phenomenon of patients discovering mid-treatment that their hospital is out-of-network. For hospitals that have deliberately exited certain MA plans, accurate directory information ensures that beneficiaries know upfront which plans their hospital accepts, potentially influencing plan selection during open enrollment in ways that favor MA plans with broader and more stable hospital networks.

On the other hand, the new update requirements impose administrative obligations. Hospitals and health systems must ensure that changes to their network participation status — whether by choice or due to contract termination — are communicated to plans in time for the 30-day update requirement to be met. For large health systems with complex contracting relationships across dozens of MA plans, this requires investment in administrative infrastructure and coordination.

The directory also has implications for the ongoing hospital-MA insurer negotiations. When plan networks are publicly visible and searchable on a federal platform, network inadequacy becomes easier to document and harder to obscure. Hospitals that have left MA networks, and advocates who argue that departures reflect systemic MA reimbursement failures rather than provider preferences, will find the centralized directory a more powerful evidentiary tool.

Limitations and the Road Ahead

While the CMS federal directory initiative represents meaningful progress, several important limitations warrant candid acknowledgment. The most fundamental is that directory accuracy is ultimately only as good as the data plans provide — and plans have historically demonstrated limited reliability in maintaining current directory information. Attestation requirements raise the stakes for inaccuracy, but enforcement mechanisms remain to be tested. CMS has not historically imposed significant sanctions on plans for network adequacy or directory failures, a pattern the OIG explicitly noted in recommending stronger enforcement.

The decision not to link directory attestation to network adequacy compliance submissions also leaves a gap. A plan could theoretically maintain a technically adequate network on paper while still producing a directory that imperfectly reflects the providers actively accepting plan members. These two dimensions of the problem — network adequacy and directory accuracy — are related but distinct, and addressing only one limits the reform’s reach.

The 2026-2027 transition timeline means beneficiaries navigating the 2026 open enrollment period still relied on third-party vendor data of uncertain accuracy. CMS has acknowledged that data quality issues existed even in the interim directory. A Washington Post investigation found duplicative addresses and providers appearing simultaneously as both in-network and out-of-network in the early version of the tool.

Looking ahead, the success of the federal directory initiative will depend heavily on CMS’s willingness to audit plan-submitted data, enforce update requirements, and impose meaningful consequences for material inaccuracies. It will also depend on investment in the technical infrastructure needed to receive, validate, and display accurate provider data at scale across hundreds of plans and tens of millions of enrollees.

Conclusion

CMS’s federal directory of Medicare Advantage hospitals and physicians addresses a genuine, long-documented failure in one of the largest insurance programs in American history. Ghost networks — providers listed in directories who are not actually available to plan members — have harmed beneficiaries, eroded trust in Medicare Advantage, and undermined the program’s core promise of informed consumer choice. The new regulatory framework, requiring plans to submit standardized provider data to CMS for centralized publication, with 30-day update requirements and annual attestation, marks a structural improvement over the decentralized, plan-managed status quo.

At the same time, the initiative’s ultimate impact will be determined not by the rule itself but by its implementation, enforcement, and evolution. Transparency is a necessary but not sufficient condition for accountability. The federal directory creates visibility; whether that visibility translates into improved access and plan behavior depends on CMS’s follow-through and Congress’s willingness to back the agency with adequate enforcement authority. For 32 million Medicare Advantage enrollees, the stakes could hardly be higher.

If you enjoyed this piece, subscribe to our monthly newsletter to receive even more in-depth insights.

Sources